LGT Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5
Closed -$3.9K 536
2025
Q2
$3.9K Buy
+5
New +$3.88K 0.01% 315
2024
Q3
Sell
-40
Closed -$36.2K 746
2024
Q2
$36.2K Buy
+40
New +$32K 0.08% 197
2024
Q1
Sell
-13
Closed -$7.58K 821
2023
Q4
$7.58K Sell
13
-25
-66% -$14.6K 0.01% 546
2023
Q3
$20.4K Buy
+38
New +$19.6K 0.03% 335

Other funds holding LLY

LGT Financial Advisors's LLY Position: Q3 2025 in Review

LGT Financial Advisors sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 5 shares — an estimated $3.9K sold.

LGT Financial Advisors first reported a position in LLY in Q3 2023 and held it in 4 quarters. The position peaked at $36.2K in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • LGT Financial Advisors reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • LGT Financial Advisors sold 5 Eli Lilly shares in Q3 2025, an estimated $3.9K.
  • LGT Financial Advisors first reported a position in Eli Lilly in Q3 2023 and held it in 4 quarters.
  • LGT Financial Advisors's Eli Lilly position peaked at $36.2K in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on LGT Financial Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.